A questionnaire survey of pediatric XXXX in India.

@entity1 @entity851 @entity417 @entity548 @entity294 @entity31 @entity29 @entity490 @entity30
BACKGROUND: @entity29 ( @entity29 ) is not uncommon in @entity1 and is an important cause of morbidity. Since information on @entity29 in Indian @entity1 is sparse, the study aimed at highlighting the salient features in them. MATERIALS AND METHODS: A questionnaire survey was done among 221 @entity1 and adolescents with @entity29 [ @entity31 ( @entity31 ) 93 (42.1  %); @entity30 ( @entity30 ) 122 (55.2  %); unclassified ( @entity29 -U) 6 (2.7  %)] across seven centers in India. The cut-off age was 18  years and below. RESULTS: The mean age of presentation for @entity31 and @entity30 was 10.2        4.4 and 11.0        4.5  years, respectively, with no gender difference. @entity294 (69.9  %, p   =   0.001) and blood in the stools (90.3  %, p   =   0.0001) were common in @entity31 , whereas @entity490 (73.8  %, p   =   0.01), fever (39.3  %, p   =   0.0001), @entity417 (64.7  %, p   =   0.001), and @entity851 (76.2  %, p   =   0.0001) were common in @entity30 . Extraintestinal manifestations (EIM) were a feature in 23.6 % and 36.1  % of @entity31 and @entity30 , respectively. Pancolitis (E3) was predominant in @entity31 (70.9  %) and 88  % required steroids. Ileocolonic @entity30 (L3) was common in 72.9  %; 76.2  % required azathioprine for maintenance. Of the @entity1 with @entity31 , 11.8  % had complications like @entity548 and toxic megacolon, while 27  % of @entity30 had fistulae, perianal abscess, stricture, and perforation. Biologicals were used in 0.8  % of severe @entity31 and in 12.2  % of @entity30 . In @entity31 , 4.3  % required surgical intervention. CONCLUSION: @entity29 ( @entity29 ) in India shares similarities with adult-onset @entity29 . Distinctive features were @entity851 and more severe forms of the disease necessitating immunomodulators.
